Volume 40 Supplement 1

70th Congress of the Italian Society of Pediatrics

Open Access

The children with microcytosis

  • Bruno Nobili1,
  • Sofia MR Matarese1 and
  • Francesca Rossi1
Italian Journal of Pediatrics201440(Suppl 1):A14

https://doi.org/10.1186/1824-7288-40-S1-A14

Published: 11 August 2014

Microcytosis is decrease of red blood cells (RBCs) size. The RBCs size is measured by the mean corpuscular volume (MCV). In the children, MCV varies by age and sex and so it must be always compared with sex and age-based norms. A MCV less than the 5th percentile defines the children microcytosis . The most frequent causes of microcytosis are iron deficiency anaemia (IDA) and haemoglobinopathies [1].

IDA is the most prevalent acquired anemia, due to iron deficiency (ID), resulting from negative iron balance. Three are the commonest causes of ID: low dietary iron intake, malabsorption and blood losses. Children are particularly vulnerable to ID because of their increased iron requirements in the periods of rapid growth. IDA causes delay in cognitive development and poor motor and sensory system functioning. Therefore, it is very important to detect ID at its earliest stage in children and replenish the iron stores by proper supplementation [1].

Hemoglobinopathies constitute a major health problem worldwide with a high carrier frequency particularly in regions where malaria has been endemic.

These disorders are characterized by a clinical and hematological phenotypic heterogeneity. Differentiation between thalassemic and non thalassemic microcytosis has important clinical implications, because each has an entirely different pathogenesis, prognosis, and treatment [13].

Differential diagnosis requires hematological marker measurement (RBCs, MCV, RBC distribution width or RDW, which measures RBC size variance. An elevated RDW indicates RBCs of multiple sizes), quantification of HbA2 and HbF, detection of Hb variants by HPLC and valuation of iron status (measurement of ferritin, which reflects iron stores, and transferring or total iron-binding capacity, which indicates the body’s ability to transport iron for use in RBC production) [2, 3].

In β thalassemia trait (βTT), the RBC count is generally higher than in IDA patients , whereas MCV value is lower. RDW is increased in anemic patients with respect to the healthy subjects, higher in IDA than βTT. The negative iron balance is a marker of ID, while the increase of HbA2 is a marker of βTT[2, 3].In recent years, the identification of new proteins involved in iron trafficking and regulation have led to the discovery of new forms of hereditary microcytosis, sharing features with the classic IDA. A careful patient history and evaluation of laboratory tests may enable these rare conditions to be distinguished from the more common IDA. Molecular studies allow distinction of the different types, a prerequisite for differentiated therapy [4, 5].

Authors’ Affiliations

(1)
Department of Woman, Children and General and Specialistic Surgery, Second University of Naples

References

  1. Oski FA: A diagnostic approach to the anemic patient. Nathan and Oski’s Hematology of Infancy and Childhood. 2003, Philadelphia, Pa.: Saunders, 409-418. 6Google Scholar
  2. Urrechaga E, Borque L, Escanero JF: Erythrocyte and Reticulocyte Parameters in Iron Deficiency and Thalassemia. J Clin Lab Anal. 2011, 25: 223-228. 10.1002/jcla.20462.View ArticlePubMedGoogle Scholar
  3. Schoorl M, Linssen J, Villanueva MM, NoGuera JA, Martinez PH, Bartels PC: Efficacy of Advanced Discriminating Algorithms for Screening on Iron-Deficiency Anemia and β-Thalassemia Trait. Am J Clin Pathol. 2012, 138: 300-304. 10.1309/AJCP20UTTCAYKUDX.View ArticlePubMedGoogle Scholar
  4. Camaschella C: How I manage patients with atypical microcytic anaemia. Br J Haematol. 2012, 160: 12-24.View ArticlePubMedGoogle Scholar
  5. De Falco L, Sanchez M, Silvestri L, Kannengiesser C, Muckenthaler MU, Iolascon A, Gouya L, Camaschella C, Beaumont C: Iron refractory iron deficiency anemia. Haematologica. 2013, 98: 845-53. 10.3324/haematol.2012.075515.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Nobili et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement